189 related articles for article (PubMed ID: 26391915)
1. Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro.
Morad HO; Belete SC; Read T; Shaw AM
J Immunol Methods; 2015 Dec; 427():13-8. PubMed ID: 26391915
[TBL] [Abstract][Full Text] [Related]
2. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
[TBL] [Abstract][Full Text] [Related]
3. Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.
Wust SK; Blumenthal MN; Corazalla EO; Benson BA; Dalmasso AP
Transl Res; 2006 Oct; 148(4):157-63. PubMed ID: 17002917
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
Williams JJ; Yellin SA; Slotman GJ
Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
[TBL] [Abstract][Full Text] [Related]
6. Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.
Banda NK; Levitt B; Wood AK; Takahashi K; Stahl GL; Holers VM; Arend WP
Clin Exp Immunol; 2010 Jan; 159(1):100-8. PubMed ID: 19843088
[TBL] [Abstract][Full Text] [Related]
7. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
[TBL] [Abstract][Full Text] [Related]
8. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
[TBL] [Abstract][Full Text] [Related]
9. Alterations in plasma complement levels after human ischemic stroke.
Mocco J; Wilson DA; Komotar RJ; Sughrue ME; Coates K; Sacco RL; Elkind MS; Connolly ES
Neurosurgery; 2006 Jul; 59(1):28-33; discussion 28-33. PubMed ID: 16823297
[TBL] [Abstract][Full Text] [Related]
10. Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress.
Enskog A; Bengtsson A; Bengtson JP; Heideman M; Andreasson S; Larsson L
Eur J Pediatr; 1996 Jan; 155(1):41-5. PubMed ID: 8750809
[TBL] [Abstract][Full Text] [Related]
11. Excretions/secretions from medicinal larvae (Lucilia sericata) inhibit complement activation by two mechanisms.
Tamura T; Cazander G; Rooijakkers SH; Trouw LA; Nibbering PH
Wound Repair Regen; 2017 Jan; 25(1):41-50. PubMed ID: 28019718
[TBL] [Abstract][Full Text] [Related]
12. Hemofiltration modifies complement activation after extracorporeal circulation in infants.
Andreasson S; Göthberg S; Berggren H; Bengtsson A; Eriksson E; Risberg B
Ann Thorac Surg; 1993 Dec; 56(6):1515-7. PubMed ID: 8267479
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
Vachino G; Gelfand JA; Atkins MB; Tamerius JD; Demchak P; Mier JW
Blood; 1991 Nov; 78(10):2505-13. PubMed ID: 1824247
[TBL] [Abstract][Full Text] [Related]
14. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
[TBL] [Abstract][Full Text] [Related]
15. Relative inefficiency of terminal complement activation.
Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
[TBL] [Abstract][Full Text] [Related]
16. [Effects of nicotine and cigarette smoke extracts on plasma level of complement C3a and C5a, thromboxane B2 and 6-keto PGF1 alpha in rabbits].
Kihira Y; Kobayashi J; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Dec; 27(12):1495-501. PubMed ID: 2630770
[TBL] [Abstract][Full Text] [Related]
17. Role of C3 cleavage in monocyte activation during extracorporeal circulation.
Rinder CS; Rinder HM; Johnson K; Smith M; Lee DL; Tracey J; Polack G; Higgins P; Yeh CG; Smith BR
Circulation; 1999 Aug; 100(5):553-8. PubMed ID: 10430771
[TBL] [Abstract][Full Text] [Related]
18. Complement activation by dental implants.
Perala D; Chapman R; Gelfand J
Int J Oral Maxillofac Implants; 1991; 6(2):136-41. PubMed ID: 1809667
[TBL] [Abstract][Full Text] [Related]
19. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
[TBL] [Abstract][Full Text] [Related]
20. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
